Deleted form of hepatocyte growth factor ameliorates the mortality rate of severe thermal injury in rats

Surgery

Volumn 126, Issue 5, 1999, Pages 925-932

  Arisawa, Hirohiko ^a   Yamashita, Yasushi ^a   Ogawa, Hiromi ^a   Masunaga, Hiroaki ^a   Higashio, Kanji ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 2 GLOBULIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MUTANT PROTEIN; PROTEIN; SCATTER FACTOR; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DELETION MUTANT; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; INTRAVENOUS DRUG ADMINISTRATION; LIVER WEIGHT; MALE; MORTALITY; NONHUMAN; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; RAT; THERMAL INJURY; TREATMENT OUTCOME;

EID: 0032744578     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70034-6     Document Type: Article

References (39)

1. 1. Nakamura T, Teramoto H. Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986;83:6489-93.
2. 2. Gherardi E, Stoker M. Hepatocytes and scatter factor. Nature 1990;346:228.
3. 3. Montesano R, Schaller G, Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 1991;66:697-711.
4. 4. Higashio K, Shima N, Goto M, Itagaki Y, Nagao M, Yasuda H, et al. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem Biophys Res Commum 1990;170:397-404.
5. 5. Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A, Higashio K. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commum 1991;170:1151-8.
6. 6. Shima N, Tsuda E, Goto M, Yano K, Hayasaka H, Ueda M, et al. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable by their biological activity and tertiary structure. Biochem Biophys Res Commum 1994;200:808-15.
7. 7. Daniels JC, Larson DL, Abston S, Ritzmann SE. Serum protein profiles in thermal burns. I. Serum electrophoretic patterns, immunoglobulins, and transport proteins. J Trauma 1974;14:137-52.
8. 8. Moody BJ. Changes in the serum concentrations of thyroxine-binding prealbumin and retinol-binding protein following burn injury. Clin Chim Acta 1982;118:87-92.
9. 9. Moody BJ, Shakespeare PG, Batstone GF. The effects of septic complications upon the serum protein changes associated with thermal injury. Ann Clin Biochem 1985;22:391-6.
10. 10. Brown WL, Bowler EG, Mason AD Jr, Pruitt BA Jr. Protein metabolism in burned rats. Am J Physiol 1976;231:476-82.
11. 11. Xia ZF, Coolbaugh MI, He F, Herndon DN, Papaconstantinou J. The effects of burn injury on the acute phase response. J Trauma 1992;32:245-51.
12. 12. Schreiber G, Tsykin A, Aldred AR, Thomas T, Fung WP, Dickson PW, et al. The acute phase response in the rodent. Ann N Y Acad Sci 1989;557:61-85.
13. 13. Hiyama DT, von Allmen D, Rosenblum L, Ogle CK, Hasselgren PO, Fischer JE. Synthesis of albumin and acute-phase proteins in perfused liver after burn injury in rats. J Burn Care Rehabil 1991;12:1-6.
14. 14. Dickson PW, Bannister DE, Schreiber G. Minor burns lead to major changes in synthesis rates of plasma proteins in the liver. J Trauma 1987;27:283-6.
15. 15. Sganga G, Siegel JH, Brown G, Coleman B, Wiles CE III, Belzberg H, et al. Reprioritization of hepatic plasma protein release in trauma and sepsis. Arch Surg 1985;120:187-99.
16. 1-antitrypsin correlates with sensitivity to thermal injury. Surgery 1996;119:664-73.
17. 17. Gilpin DA, Hsieh CC, Kuninger DT, Herndon DN, Papaconstantinou J. Effect of thermal injury on the expression of transcription factors that regulate acute phase response genes: the response of C/EBP α, C/EBP β, C/EBP δ to thermal injury. Surgery 1996;119:674-83.
18. 18. Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology. Part III: albumin and disease states. JPEN 1991;15:476-83.
19. 19. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commum 1984;122:1450-9.
20. 20. Masunaga H, Fujise N, Shiota A, Yamashita Y, Yasuda H, Higashio K. Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats. J Pharm Pharmacol 1996;48:876-9.
21. 21. Masunaga H, Fujise N, Shiota A, Ogawa H, Sato Y, Imai E, et al. Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries. Eur J Pharmacol 1998;342:267-79.
22. 22. Furth J, Sobel H. Hypervolemia secondary to grafted granulosa-cell tumor. J Natl Cancer Inst 1946;7:103-13.
23. 23. Walker HL, Mason AD Jr. A standard animal burn. J Trauma 1968;8:1049-51.
24. 24. Kanai M H. Plasma protein. In: Totsuka M, editors. Clinical laboratory chemistry: textbook of clinical laboratory examination [in Japanese]. 30th ed. Tokyo: Kanehara & Co; 1994. p. 480-505.
25. 25. Kien ND, Antognini JF, Reilly DA, Moore PG. Small-volume resuscitation using hypertonic saline improves organ perfusion in burned rats. Anesth Analg 1996;83:782-8.
26. 26. Ogle CK, Alexander JW. The relationship of bacteremia to levels of transferrin, albumin and total serum protein in burn patients. Burns 1981;8:32-8.
27. 27. Reinhardt GF, Myscofski JW, Wilkens DB, Dobrin PB, Mangan JE Jr, Stannard RT. Incidence and mortality of hypoalbuminemic patients in hospitalized veterans. JPEN 1980;4:357-9.
28. 28. Anderson CF, Wochos DN. The utility of serum albumin values in the nutritional assessment of hospitalized patients. Mayo Clin Proc 1982;57:181-4.
29. 29. Weinberg ED. Iron and susceptivity to infectious disease. Science 1974;184:952-6.
30. 30. Fletcher F. The effect of iron and transferrin on the killing of Escherichia coli in fresh serum. Immunology 1971;20:493-500.
31. 31. Majumdar C, Tsukada K, Lieberman I. Liver protein synthesis after partial hepatectomy and acute stress. J Biol Chem 1967;242:700-4.
32. 32. Radding CM, Bragdon JH, Steinberg D. The synthesis of low- and high-density lipoproteins by rat liver in vitro. Biochem Biophys Acta 1958;30:443-4.
33. 33. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
34. 34. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. The immune system. In: Alt F, Mitchison A, Paul W, Schwarts R, Standring D, editors. Molecular biology of the cell. 2nd ed. New York: Garland Publishing: 1989. p. 1002-58.
35. 35. Shimazaki S. Changes of immune system. In: Sinozawa Y, editors. Pathogenesis on burn injury. Textbook of burn injury [in Japanese]. Tokyo: Tyugaiigakusya; 1985. p. 69-83.
36. 36. Herndon DN, Pierre EJ, Stokes KN, Barrow RE. Growth hormone treatment for burned children. Horm Res 1996;45(suppl):29-31.
37. 37. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994;220:19-24.
38. 38. Petersen SR, Jeevanandam M, Shahbazian LM, Holaday NJ. Reprioritization of liver protein synthesis resulting from recombinant human growth hormone supplementation in parenterally fed trauma patients: the effect of growth hormone on the acute-phase response. J Trauma 1997;42:987-96.
39. 39. Roth E, Valentini L, Semsroth M, Holzenbein T, Winkler S, Blum WF, et al. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J Trauma 1995;38:136-41.